ALPHAMAB ONCOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 9966 for the last semiannual is 188.07 M HKD, and it's 111.51% higher compared to the previous semiannual. The net income of H1 24 is -48.65 M HKD.